Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bioterrorism -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (391)	10/30/2001 9:50:18 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 891

Thus his own venture: a plan to develop a spray that would kick-start the general immunologic defenses of the mucous membranes lining the nose, throat and lungs. At the first sign of a terrorist attack, Alibek said, people in danger zones could use such a spray, perhaps stockpiled in their homes and offices for such an emergency. This could happen even before scientists knew what germ was involved. The spray would rev up a person's immune system to fight the germ. It would be just a first line of defense — once the germ was identified, more specific treatments or preventives might be deployed, if available. The strategy might not save the entire population of a city under attack, Alibek said, but it could save a large percentage. A second generation echinacea, if you like. I believe in this approach, and there's tons of experimental evidence to support it. Think anti-TNF and an increased susceptibility to intracellular bacterial pathogens, for example.